Tretinoin 0.025%
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tretinoin 0.025%, covering 2012-06-15 to 2017-07-18. Get the full timeline:
Most recent: Clinical Trial Update: W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers [Phase 1]